Pfizer Fined $2.3 Billion For Improper Marketing

September 3, 2009 at 11:04 am  ·  Category: Business Culture and Current Events, Culture and Current Events, Stocks

The Pfizer unit Pharmacia & Upjohn pleaded guilty to a single felony charge that accused the company of marketing its anti-inflammatory drug Bextra for broader uses and higher dosages than those approved by the Food and Drug Administration.

“In Settlement, A Warning To Drugmakers”, The Washington Post, September 3, A1

Yikes!

pfe-2-day-chart

Disclosure: Top Gun is long share of Pfizer (PFE).

Posted by Greg Feirman  ·  Trackback URL  ·  Link
 

Leave a Comment

Name required
E-mail required, won't be published
Web site